<DOC>
	<DOCNO>NCT01021280</DOCNO>
	<brief_summary>Parathyroid hormone ( PTH ) gland calcium sensing receptor ( CASR ) regulate PTH secretion . CASR also express nephron thick ascend limb ( TAL ) . Bartter syndrome ( BS ) , normotensive hypokalemic tubulopathy , may due mutation different TAL channel , include potassium channel ROMK . Mutations CASR may also cause BS effect ROMK function . However , unknown whether ROMK mutation exert effect CASR function PTH physiology . Preliminary data center show PTH level specifically elevate type II ( ROMK mutate ) type IV ( another gene , Barttin defective ) BS , without common explanation . We assume mutation ROMK may cause dysregulation PTH secretion via possible interaction CASR . The purpose study : investigate PT-gland function regulation BS . Methods : Patients BS type II IV normal control undergo standard protocol control ionic hypo- hypercalcemia , PTH secretion , phosphate balance calcium excretion follow . Calcium Vs PTH response curve generate compare . Expected impact benefit : result study help understand mechanism PTH regulation beyond CASR .</brief_summary>
	<brief_title>Parathyroid Hormone ( PTH ) Homeostasis Bartter Syndrome</brief_title>
	<detailed_description>The parathyroid glands play pivotal physiological function maintain blood calcium level , specifically blood ionized calcium concentration , within narrow range . They modulate minute-to-minute release parathyroid hormone ( PTH ) circulation . Such change almost immediate effect calcium excretion urine calcium efflux bone , sustain hour day , affect renal vitamin D metabolism ultimately efficiency intestinal calcium absorption . The capacity chief cell parathyroid detect small change blood ionized calcium level , modify PTH release accordingly , initiate adaptive response mediate calcium-sensing receptor ( CaSR ) locate cell surface . The importance CaSR parathyroid tissue extend beyond traditional role modifier calcium-regulated PTH secretion involve key component parathyroid gland function frequently abnormal clinical disorder characterize excess parathyroid gland activity hyperparathyroidism . These include disturbance control PTH gene transcription hormone synthesis development parathyroid gland enlargement due tissue hyperplasia . PTH act mainly renal proximal tubule phosphorus ( Pi ) reabsorption bone osteoclast calcium Pi resorption . CASR also express nephron thick ascend limb ( TAL ) , interact luminal potassium ROMK channel . Mutations several TAL channel protein ( include ROMK , NKCC2 , ClCKb , Barttin CASR ) cause Bartter syndrome ( BS ) , normotensive hypokalemic tubulopathy . Whereas effect CASR mutation ROMK function kidney describe , unknown whether ROMK mutation exert effect CASR function PTH regulation . We describe group child adolescents type II BS ( due mutation ROMK ) abnormal PTH homeostasis . Preliminary Data : We compare laboratory data 12 child type II BS ( 4M , 8F ) 17 child ( 7M , 10F ) type IV BS ( d/t mutation Barttin gene , beta subunit ClCKb basolateral chloride channel TAL ) , follow center past 10 year . A total 86 105 datasets blood urine analysis ( average datasets/pt : 7.3±4.1 6.9±2.9 ) , type II IV BS respectively , analyzed.Potassium level normal BS-II child without additional salt supplementation , whereas BS-IV child usually mildly hypokalemic . Estimated GFR remain normal child . There hypomagnesemia . Average PTH value significantly high BS-II ( 102±39 Vs 46±24 pg/ml BS-IV , p &lt; 0.001 ) upper normal limit 93 % case Vs 13 % BS-IV ( p &lt; 0.001 ) . Levels 25 ( OH ) vitamin D different . Total serum calcium mildly decrease ( within normal range ) serum Pi increase BS-II , absolute value normalize age ( PiSDS ) . The threshold phosphate excretion ( TpGFR ) slightly high BS-II . There difference degree hypercalciuria group . Based preliminary data conclude elevated PTH level type II BS related decrease GFR vitamin D level decrease serum calcium hypercalciuria . The elevated Pi level associate decrease phosphate excretion , correlate PTH level . The possibility mutation ROMK may cause dysregulation PTH secretion via possible interaction CASR investigate . Methods : The investigative protocol submit local Committee Human Experimentation . Informed consent obtain affected child ( young adult ) parent . We expect recruit 5 patient BS subgroup . In addition recruit 5 normal volunteer serve additional control group . Subjects evaluate 2-day admission General Pediatric Ward previously describe . On first day study , 2-h I.V . infusion sodium citrate do gradually low blood ionized calcium concentration level least 0.2 mmol/L preinfusion value ; dose sodium citrate range usually 28-118 mg/kg/h . Blood sample measurement ionized calcium PTH obtain 30 , 15 , 0 min every 10 min sodium citrate infusion . The following day , 2-h IV infusion 10 % calcium gluconate do gradually raise blood ionized calcium concentration level least 0.2 mmol/L preinfusion value . The dose calcium gluconate usually range 2-8 mg/kg/h . Blood sample measurement ionized calcium PTH obtain describe previously infusion sodium citrate . The average measurement obtain 30 , 15 , 0 min start infusion use determine basal value blood ionized calcium serum PTH day study . Blood ionized calcium level monitor calcium infusion use calcium-specific electrode ( Radiometer ICA-II , Copenhagen , Denmark ) ; blood sample collect anaerobically , measurement obtain immediately thereafter . Serum sample PTH determination separate centrifugation immediately collection , snap frozen solid CO2 , store -70 oC assay . Ionized calcium level monitor stop calcium infusion value return baseline level . The sigmoidal curve describes relationship blood ionized calcium serum PTH level determine study subject use combined result obtain sodium citrate calcium gluconate infusion . According four parameter model , set point calcium-regulated PTH release represent ionized calcium concentration serum PTH level midway maximum value achieve hypocalcemia minimum value attain hypercalcemia , report previously . Results obtain calcium gluconate infusion separately analyze assess inhibitory effect increase blood ionized calcium concentration PTH release . To improve linear fit data , serum PTH level , express natural logarithm ( ln ) percent preinfusion value , plot correspond blood ionized calcium concentration 10-min interval previously describe . Statistical Analysis : Linear regression analysis do use method least square , slope y-intercept value compare use statistic . A mono-exponential curve fit algorithm form =A e-2kt + B also use examine curvilinear relationship blood ionized calcium serum PTH level I.V . calcium infusion ; result present mean value 95 % confidence interval .</detailed_description>
	<mesh_term>Hypocalcemia</mesh_term>
	<mesh_term>Hypercalcemia</mesh_term>
	<mesh_term>Bartter Syndrome</mesh_term>
	<criteria>Bartter syndrome Normal Vitamin D status Age &lt; 14 yr</criteria>
	<gender>All</gender>
	<minimum_age>14 Years</minimum_age>
	<maximum_age>35 Years</maximum_age>
	<verification_date>June 2012</verification_date>
	<keyword>Bartter syndrome ,</keyword>
	<keyword>parathyroid hormone ,</keyword>
	<keyword>calcium sense receptor ,</keyword>
	<keyword>ROMK channel</keyword>
	<keyword>Barttin gene</keyword>
	<keyword>PTH response hypo- hypercalcemia</keyword>
</DOC>